Zoghbi, Sami S.

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 1,291

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry

Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 587

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease

Kreisl, W. C., Lyoo, C. H., McGwier, M., Snow, J., Jenko, K. J., Kimura, N., Corona, W., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2013) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 350

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S., & Innis, R. B. (2000) · American Journal of Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 222

The Inhibitor Ko143 Is Not Specific for ABCG2

Weidner, L. D., Zoghbi, S. S., Lu, S., Shukla, S., Ambudkar, S. V., Pike, V. W., Mulder, J., Gottesman, M. M., Innis, R. B., & Hall, M. D. (2015) · The Journal of Pharmacology and Experimental Therapeutics

Drug Transport and Resistance MechanismsBarrier Structure and Function Studies

Cited by 141

Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123I]5-I-A-85380 in healthy human subjects

Fujita, M., Seibyl, J. P., Vaupel, B. D., Tamagnan, G., Early, M., Zoghbi, S. S., Baldwin, R. M., Horti, A. G., Koren, A. O., Mukhin, A. G., et al. (2002) · European Journal of Nuclear Medicine and Molecular Imaging

Radiopharmaceutical Chemistry and ApplicationsNicotinic Acetylcholine Receptors Study

Cited by 62

Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents

Terry, G., Liow, J.-S., Chernet, E., Zoghbi, S. S., Phebus, L., Felder, C. C., Tauscher, J., Schaus, J. M., Pike, V. W., Halldin, C., et al. (2008) · NeuroImage

Cannabis and Cannabinoid ResearchRadiopharmaceutical Chemistry and Applications

Cited by 51

Influence of acetylcholine levels on the binding of a SPECT nicotinic acetylcholine receptor ligand [123I]5‐I‐A‐85380

Fujita, M., Al‐Tikriti, M. S., Tamagnan, G., Zoghbi, S. S., Bozkurt, A., Baldwin, R. M., & Innis, R. B. (2003) · Synapse

Nicotinic Acetylcholine Receptors StudyRadiopharmaceutical Chemistry and Applications

Cited by 24

Chemical fate of the nicotinic acetylcholinergic radiotracer [123I]5-IA-85380 in baboon brain and plasma

Baldwin, R. M., Zoghbi, S. S., Staley, J. K., Brenner, E., Al-Tikriti, M. S., Amici, L., Fujita, M., Innis, R. B., & Tamagnan, G. (2006) · Nuclear Medicine and Biology

Radiopharmaceutical Chemistry and ApplicationsNicotinic Acetylcholine Receptors Study

Cited by 6